fr
Article scientifique
Anglais

Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients

Publié dansClinical transplantation, vol. 25, no. 4, p. 660-669
Date de publication2011
Résumé

The aim of this study was to evaluate the tolerability of the conversion from calcineurin inhibitor (CNI) to everolimus (ERL) in maintenance liver transplant (LT) recipients.

Mots-clés
  • Calcineurin/antagonists & inhibitors
  • Cohort Studies
  • Cyclosporine/therapeutic use
  • Female
  • Follow-Up Studies
  • Graft Rejection/drug therapy
  • Graft Survival
  • Humans
  • Immune Tolerance/drug effects
  • Immunosuppressive Agents/therapeutic use
  • Liver Transplantation
  • Male
  • Middle Aged
  • Sirolimus/analogs & derivatives/therapeutic use
  • Survival Rate
  • Tacrolimus/therapeutic use
  • Treatment Outcome
Citation (format ISO)
VALLIN, Mélanie et al. Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients. In: Clinical transplantation, 2011, vol. 25, n° 4, p. 660–669. doi: 10.1111/j.1399-0012.2010.01370.x
Fichiers principaux (1)
Article (Published version)
accessLevelRestricted
Identifiants
ISSN du journal0902-0063
545vues
0téléchargements

Informations techniques

Création17.12.2012 15:54:00
Première validation17.12.2012 15:54:00
Heure de mise à jour14.03.2023 19:55:05
Changement de statut14.03.2023 19:55:05
Dernière indexation16.01.2024 00:50:26
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack